
Signature
Dave ©¿©
"Ego sum quis Ego sum quod ut est quicumque Ego sum"
http://www.howdydave.com
And the report is 4 years old next January (publication date at end)-- you'd
think Med. Staffs would have reacted by now for those who have GM or PM
szrs. (I don't). G./
> Howdy!
>
[quoted text clipped - 11 lines]
>>
>> Epilepsia, January, 2002
Darwin - 03 Oct 2005 23:58 GMT
Any beneficial effect of n-3 PUFAs is certainly not well established. Our
lab has only just started looking at them in animal models of epilepsy as
opposed to the ketogenic diet, which doesn't work well in animal models.
> And the report is 4 years old next January (publication date at end)--
> you'd think Med. Staffs would have reacted by now for those who have GM or
[quoted text clipped - 15 lines]
>>>
>>> Epilepsia, January, 2002
Granted this was a small study, however the results were quite
dramatic.
The frequency of grand mal seizures before the omega-3 diet and after
were as follows:
Patient 1 - Grand mal seizures before were 2-3 per week and after
zero.
Patient 2 - Grand mal seizures before were 6-8 per week and after
zero.
Patient 3 - Grand mal seizures before were 1-2 per week and after 1
per month.
Patient 4 - Grand mal seizures before were 1-2 per week and after
zero.
Patient 5 - Grand mal seizures before were 14 per week and after 3
per week.
E.B. - 05 Oct 2005 04:01 GMT
Well, here's my 2 cents:
1st penny: It really would be nice to ever get any follow-up info,
even if it was only on 5 people.
2nd penny: If it was so great, where is the follow-up?
Hmmm...sounds...Omega-3s!?!? some big dudes would lose some big money
if it did this, maybe it had to be crushed!?!?
>From someone whose medicine costs more than his income (and remember,
these comments are only worth 1 cent each) ;)
E.B.
G.Ross - 05 Oct 2005 04:42 GMT
> Granted this was a small study, however the results were quite
> dramatic.
[quoted text clipped - 12 lines]
> Patient 5 - Grand mal seizures before were 14 per week and after 3
> per week.
But the post Darwin did yesterday (on this thread) said their lab (don't
recall where it is), just started doing animal models. That's normally done
for months to 1+ years? before human tests and placebos are done ?? How did
Patients 1-5 (quoted above) get into the tests when the animal studies
hadn't been done yet? I think that was what one of the earlier posters
was getting at. G./
Darwin - 05 Oct 2005 06:44 GMT
> > Granted this was a small study, however the results were quite
> > dramatic.
[quoted text clipped - 19 lines]
> hadn't been done yet? I think that was what one of the earlier posters
> was getting at. G./
Well, for things which are already considered foods and not drugs it might
be a lot easier to get approval for trials in humans. Think of the
ketogenic diet, Atkins diet and now n-3 PUFAs...all used in humans before
tried in animal models of epilepsy. If there's any sign of a benefit then
details of the mechanism can be worked out in animal models to try to make
the effect more reliable and to try to predict what seizure types it might
be most effective on.
G.Ross - 05 Oct 2005 13:40 GMT
> "G.Ross" > wrote in message
>>
[quoted text clipped - 33 lines]
> the effect more reliable and to try to predict what seizure types it might
> be most effective on.
I was thinking more of things like MSG, thalidomide and ?? (preservative
used in fast foods (trans fats?) that is currently being linked to Childhood
Obesity in our Schools in Canada, and U.S.? ).
I guess the fact something is already approved, doesn't matter a whole
lot to me. Lots of things had once been already approved. It wouldn't
apply for me as I'm controlled, but some of us were raising a flag that the
fact something got approved for other things, when less was known about why
they worked, or might have bypassed approvals for the use it's been added,
might yet require some kind of scutiny to see there are no adverse effects
that weren't anticipated ? I don't know if any of the 3 at top were tested
in animal trials, or whether the problems that *turned up later would have
been caught with that type of testing.
The ketogenic diet only works for a small percent of people (usually
children because of high fat intake required to trigger ketosis), and is
used for people where medications might be too strong, or which had failed.
Keto for one, is not tried First usually, but after all else has failed..
/G..
Dave ©¿©¬ - 05 Oct 2005 07:20 GMT
Howdy!
With such a small case study "results" don't impress me due to the fact that
there is such a HUGE margine of error.
Since we are only talking about 5 people, it is possible that these 5
particular people had ABNORMAL results.
Results are one thing, conclusive evidence is another.

Signature
Dave ©¿©
"Ego sum quis Ego sum quod ut est quicumque Ego sum"
http://www.howdydave.com
> Granted this was a small study, however the results were quite
> dramatic.
[quoted text clipped - 12 lines]
> Patient 5 - Grand mal seizures before were 14 per week and after 3
> per week.
Darwin - 07 Oct 2005 01:32 GMT
> Granted this was a small study, however the results were quite
> dramatic.
[quoted text clipped - 12 lines]
> Patient 5 - Grand mal seizures before were 14 per week and after 3
> per week.
Here's a larger study (58 patients) that found that seizure reduction (fish
oils) was temporary (less than 6 weeks), with no effect on generalized
tonic-clonic seizures. Interestingly, the placebo group (non-fish oils)
seemed to have a much greater reduction in seizure frequency. When the
placebo group was placed on omega-3 their seizure frequency increased.
Perhaps the non-fish oils should be investigated instead of omega-3s.
1: Epilepsy Behav. 2005 Sep;7(2):253-8.
Omega-3 fatty acid supplementation in patients with chronic epilepsy: A
randomized trial.
Yuen AW, Sander JW, Fluegel D, Patsalos PN, Bell GS, Johnson T, Koepp MJ.
Department of Clinical and Experimental Epilepsy, UCL Institute of
Neurology,
London, UK; National Society for Epilepsy, Chalfont St. Peter, UK.
Animal studies and a preliminary clinical observation suggest that
nutritional
supplementation with long chain omega-3 fatty acids (omega-3 FAs) may be
useful
in the nonpharmacological treatment of patients with epilepsy. Omega-3 FAs
increase seizure thresholds, and lower inflammatory mediators, which are
increased in patients with epilepsy. In this first randomized,
placebo-controlled parallel group trial of omega-3 FA supplementation with
1g
eicosapentaenoic acid (EPA) and 0.7g docosahexaenoic acid (DHA) daily, 57
patients completed a 12-week double-blind phase. Seizure frequency was
reduced
over the first 6 weeks of treatment in the supplement group, but this effect
was
not sustained. The supplementation produced a significant increase in EPA
and
DHA concentrations and a reciprocal fall in arachidonic and linoleic acid
concentrations. No change in serum AED concentrations was detected. Further
studies are required to examine different omega-3 FA preparations, different
doses, longer treatment duration, and larger sample sizes.